Glatiramer Acetate

Glatiramer Acetate

Glatiramer Acetate (pronounced: gla-ti-ra-mer a-ce-tate) is a medication used in the treatment of Multiple Sclerosis (MS). It is a synthetic protein that simulates myelin basic protein, a component of the myelin sheath that insulates nerve fibers in the brain and spinal cord. This medication is thought to act by suppressing the immune response against myelin.

Etymology

The term "Glatiramer" is derived from the names of the four amino acids that make up the medication: glutamic acid, lysine, alanine, and tyrosine. "Acetate" refers to the presence of an acetate group in the chemical structure of the drug.

Usage

Glatiramer Acetate is used primarily in the treatment of relapsing forms of Multiple Sclerosis to reduce the frequency of relapses. It is not a cure for MS but it can help to slow down the physical disability associated with the disease and decrease the number of flare-ups.

Administration

Glatiramer Acetate is administered by subcutaneous injection, usually once daily. The medication comes in a pre-filled syringe for ease of use.

Side Effects

Common side effects of Glatiramer Acetate include redness, pain, swelling, itching, or a lump at the injection site. More serious side effects can include chest pain, flushing, and heart palpitations.

Related Terms

• Multiple Sclerosis
• Myelin
• Amino Acids
• Subcutaneous Injection

External links

• Medical encyclopedia article on Glatiramer Acetate
• Wikipedia's article - Glatiramer Acetate

This WikiMD article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski